IL6 and neoplasm: Considering that IL-6 plays a crucial role in regulating and activating myeloid-derived suppressor cells (MDSCs) and that MDSCs can harbor anti-tumor immunity [93], it is speculated that clarithromycin may have immunomodulatory effects by decreasing IL-6 and subsequently suppressing MDSCs.